XtalPi Announces Over $400 Million Strategic Partnership with Leading Biopharma to Develop AI-Driven Oral Small Molecule GPCR Therapeutics 1
XtalPi Holdings Announces US\$400 Million Strategic Partners...
Sign in to continue:
XtalPi Holdings Announces US\$400 Million Strategic Partners...
Shanghai Bio-heart Announces Iberis® RDN System Registration...
Road King Infrastructure Limited – Key Updates on BVI Windin...
Victory Giant Technology (HuiZhou) Co., Ltd. Announces Book ...
WuXi AppTec Announces A Share Repurchase Plan for 2026 – Key...
Melco Resorts & Entertainment Limited - Credit Facilities Ne...
China Ruifeng Renewable Energy Holdings Limited Issues Suppl...
Jiangsu Expressway Increases Investment in Zijin Trust – Det...
Ocean One Holding Ltd. Annual Results 2026 – Investor Analys...
HBM Holdings: First Patients Dosed in Phase II SIRIUS COPD S...